Thomas W. Dubensky has an estimated net worth of $6.95 Million. This is based on reported shares across multiple companies, which include ADURO BIOTECH, INC., Millendo Therapeutics, Inc., and HTG MOLECULAR DIAGNOSTICS, INC.

2016 was Thomas W. Dubensky's most active year for acquiring shares with 18 total transactions. Thomas W. Dubensky's most active month to acquire stocks was the month of May. 2017 was Thomas W. Dubensky's most active year for disposing of shares, totalling 26 transactions. Thomas W. Dubensky's most active month to dispose stocks was the month of November. 2016 saw Thomas W. Dubensky paying a total of $234,922.35 for 264,800 shares, this is the most they've acquired in one year. In 2017 Thomas W. Dubensky cashed out on 600,000 shares for a total of $3,193,213.18, their largest year based on trade value.